Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers

被引:78
|
作者
Beattie, Mary S. [1 ,2 ,3 ]
Crawford, Beth [2 ]
Lin, Feng [3 ]
Vittinghoff, Eric [3 ]
Ziegler, John [2 ,3 ]
机构
[1] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Comprehens Canc, Canc Risk Program, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
关键词
OVARIAN-CANCER SUSCEPTIBILITY; BREAST-CANCER; SALPINGO-OOPHORECTOMY; PROPHYLACTIC SURGERY; MUTATION CARRIERS; PREVENTIVE STRATEGIES; INHERITED MUTATIONS; GENETIC RISK; WOMEN; SURVEILLANCE;
D O I
10.1089/gtmb.2008.0067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction and Aims: For women who carry BRCA mutations, risk-reducing surgeries are an option to decrease breast and ovarian cancer risk. This study aims to determine the uptake, time course, and predictors of risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) in BRCA carriers. Results: In 272 female carriers, followed for a median of 3.7 years, 23% of those eligible chose RRM, and 51% percent chose RRSO. Among BRCA carriers who chose these procedures, median time to both RRM and RRSO was approximately 4 months after learning of BRCA-positive results. Predictors of RRM were as follows: age below 60 years (hazard ratio 1.8, p = 0.04), prior breast cancer (hazard ratio 2.4, p = 0.0004), and RRSO ( hazard ratio 7.2, p < 0.0001). Predictors of RRSO were as follows: age below 60 years (hazard ratio 3.6, p = 0.006), prior breast cancer (hazard ratio 1.8, p = 0.002), and RRM (hazard ratio 5.4, p < 0.0001). Conclusions: Many women who undergo BRCA testing use these results to make clinical decisions; those who choose risk-reducing surgeries typically do so within months of receiving BRCA-positive results. Predictors of risk-reducing surgery uptake include the following: age below 60 years, prior breast cancer, and utilization of another risk-reducing surgery. Future research directions include examining other preventive and screening options in BRCA carriers as well as studying motivations for choosing or declining risk-reducing surgeries.
引用
收藏
页码:51 / 56
页数:6
相关论文
empty
未找到相关数据